Navigation Links
Actos Lawsuit News: Bernstein Liebhard LLP Notes Latest Scheduling Order in Actos Bladder Cancer Litigation
Date:2/24/2013

New York, New York (PRWEB) February 24, 2013

Actos lawsuits continue to move forward in the federal multidistrict litigation underway in U.S. District Court, Western District of Louisiana. According to a Scheduling Order dated February 19, 2013, the Court has established a Pilot Bellwether Program, which sets up a stream-lined selection process for a minimum of two Pilot Bellwether trials. The Order stipulates that the litigation’s first Pilot Bellwether trial will begin on January 27, 2014, while the second will commence on April 14, 2014. Attorneys for both sides have been directed to nominate five Actos lawsuits each to participate in the Pilot Bellwether Discovery Pool by April 1, 2013.* (In re: Actos Product Liability Litigation, MDL No. 2299)

“The bellwether trials will provide valuable insight into how juries might weigh similar Actos claims. We look forward to this process getting underway,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free Actos bladder cancer lawsuit evaluations to individuals who may have been harmed by the medication.

Actos Bladder Cancer Lawsuits
Actos, known generically as pioglitazone, is approved as a treatment for type 2 diabetes. The U.S. Food & Drug Administration (FDA) ordered Takeda Pharmaceuticals to add new warnings to the Actos label in June 2011, after a study found that long-term use of the drug increased the risk for bladder cancer.* Since then, hundreds of people have filed Actos bladder cancer lawsuits alleging long-term use of the drug caused them to develop the disease.

The nation’s first trial involving an Actos bladder cancer lawsuit is now underway in Los Angeles Superior Court. According to a recent report
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
2. Victim’s Rights to Recover for Actos Bladder Cancer Could Expire Soon
3. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
4. Researchers Offer Explanation for Actos Bladder Cancer Risk
5. New Lawsuit alleges Actos caused Bladder Cancer
6. US Drug Watchdog Now Urges Family Members Of A Diabetic Who Died From Bladder Cancer After Using The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
7. US Drug Watchdog Now Urges Users Of The Diabetes Drug Called Actos To Call The Johnson Law Group if They Have Developed Bladder Cancer-Time Is Of The Essence
8. US Drug Watchdog Now Urges Any US Citizen Who Used the Diabetes Drug Called Actos and Then Developed Bladder Cancer To Contact The Johnson Law Group For A Legal Review
9. US Drug Watchdog Now Urges Loved Ones Of A Diabetic Who Died From Bladder Cancer Who Had Used The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
10. US Drug Watchdog Now Expands Their Efforts to Educate Diabetics About the Diabetes Drug Actos and Bladder Cancer, with the Suggestion Victims Call the Johnson Law Group
11. US Drug Watchdog Now Urges Any Diabetic Who Used the Diabetes Drug Actos and Now Have Been Diagnosed with Bladder Cancer to Call The Johnson Law Group-ASAP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... study finds a wide range of epigenetic changesalterations in ... environmental exposuresin children with Crohn,s disease (CD), reports ... Crohn,s & Colitis Foundation of America (CCFA). The ... a part of Wolters Kluwer Health . ... in several regions of the genome in children with CD, ...
(Date:8/22/2014)... Women treated for the cancer Hodgkin lymphoma will be ... after researchers estimated their risk of premature menopause with ... Journal of the National Cancer Institute , are ... women in England and Wales treated for the cancer ... Previous research has suggested that women with Hodgkin lymphoma ...
(Date:8/22/2014)... The New Jersey Institute for Food, Nutrition ... of New Jersey has joined forces with ChopChop ... young people about health and nutrition in a new ... organizations. , The partnership will encompass quarterly custom editions ... video communications. ChopChop Magazine features plenty of child-friendly ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Ticket Down ... in East Hartford, CT at Rentschler Field. There has never ... the United States than right now. After the strong showing at ... fans and the sport is being featured in large stadiums around ... an eight team tournament that featured some of the best club ...
(Date:8/22/2014)... Statesville, N.C. (PRWEB) August 22, 2014 ... the managed employee reward and recognition industry, has received ... With an extraordinary growth rate of 134%, TharpeRobbins remains ... companies in North America. TharpeRobbins was previously on the ... are honored to be included in this distinguished list ...
Breaking Medicine News(10 mins):Health News:Study shows epigenetic changes in children with Crohn's disease 2Health News:Scientists map risk of premature menopause after cancer treatment 2Health News:New Jersey Institute for Food, Nutrition & Health to Launch Innovative Partnership with Award-Winning Children’s Anti-Obesity Organization, ChopChop Kids 2Health News:New Jersey Institute for Food, Nutrition & Health to Launch Innovative Partnership with Award-Winning Children’s Anti-Obesity Organization, ChopChop Kids 3Health News:USA vs. Ecuador Tickets: Ticket Down Slashes USA (USMT) vs. Ecuador Tickets at Rentschler Field in East Hartford on Oct. 10th 2Health News:USA vs. Ecuador Tickets: Ticket Down Slashes USA (USMT) vs. Ecuador Tickets at Rentschler Field in East Hartford on Oct. 10th 3Health News:For The Fourth Time - TharpeRobbins Earns A Place On Prestigious Inc. Magazine 500|5000 List 2Health News:For The Fourth Time - TharpeRobbins Earns A Place On Prestigious Inc. Magazine 500|5000 List 3
... KUNMING, China, Sept. 13 /Xinhua-PRNewswire-FirstCall/ -- China,Shenghuo ... KUN ), which is engaged in ... nutritional supplement and cosmetic,products in the People,s ... the full-scale launch of its 12Ways(R) Chinese ...
... Sept. 13 Scimitar Equity Research, Inc.,(Scimitar) today ... Bulletin,Board: ABOS) entitled: "Enhancing the Recovery of Patients ... research review is,available on Scimitar,s website: http://www.scimitarequity.com ... Device The SEPET(TM) Liver Assist Device is ...
... correlation, with risk doubling as blood cells decline , ... declining blood platelet counts may be at increased risk ... behavioral and motor skill problems, researchers report. , Researchers ... Johns Hopkins University School of Medicine in Baltimore studied ...
... (Sept. 10, 2007) -- For high-blood-pressure patients, preventing or ... risk of heart failure. The study is published in ... by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in ... all high-blood-pressure patients, or 12 million Americans, have LVH ...
... Health Corp. is the Distributor of the Popular Dietary Supplement ... ... Health Corp. is proud to,announce its retail presence has expanded again ... and Sweet Bay,Supermarkets. LipidShield Plus is the popular NATURAL breakthrough ...
... Reports Solid Progress on Child Survival, NEW YORK, Sept. ... below 10 million per year to 9.7 million,down from almost ... an historic moment," said UNICEF Executive Director Ann M.,Veneman. "Now ... for the,achievement of the Millennium Development Goals." Among these ...
Cached Medicine News:Health News:China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line 2Health News:China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line 3Health News:China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line 4Health News:Arbios Systems, Inc's Q2/07 Analyst Review Issued by Scimitar Equity Research, Inc. 2Health News:Falling Platelet Counts May Signal HIV-Linked Dementia 2Health News:Preventing or reducing enlarged heart decreases risk of heart failure 2Health News:New Health Corp. Announces the Addition of Hannaford Bros., Kash N Karry and Sweet Bay Supermarkets to its Retail Outlets 2Health News:Child Deaths Fall Below 10 Million For First Time 2Health News:Child Deaths Fall Below 10 Million For First Time 3Health News:Child Deaths Fall Below 10 Million For First Time 4
(Date:8/21/2014)... 2014 Nektar Therapeutics (NASDAQ: ... positive results from its Phase 3 pivotal clinical ... recombinant factor VIII (rFVIII) treatment for hemophilia A ... its primary endpoint in reducing annualized bleed rates ... on-demand arm. Top-line results from the ...
(Date:8/21/2014)... The spinal column is one of the most delicate and ... from the brain through the column control many key functions ... here can be life altering, and leave the victim in ... body. Though back injury and disease can have an intensely ... available to make things better than ever before. Laser ...
(Date:8/21/2014)... 21, 2014 /CNW/ - Eisai Limited is pleased to support ... first-of-its-kind comic book available in Canada . ... specifically to educate children and their parents about epilepsy, the ... affecting more than 300,000 Canadians. Eisai is guided by a ... in which the patient is central – there was a ...
Breaking Medicine Technology:Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2
... N.J., Feb. 3, 2011 BioNeutral Group, Inc. (OTC ... science technology-based company, today announced the formation of BioNeutral ... Inc., and the appointment of Frank Battafarano as the ... BioNeutral Services will market and distribute a ...
... 2011 A VANIR Pharmaceuticals, Inc. ... the three months ended December 31, 2010. For the ... $12.1 million, or $0.11 loss per share, compared with a net ... same period in fiscal 2010. Net revenues consisting primarily of royalty ...
Cached Medicine Technology:BioNeutral Group Announces the Formation of Kentucky-Based BioNeutral Services, Inc. and the Appointment of Frank Battafarano as Chairman and CEO of BioNeutral Services, Inc. 2BioNeutral Group Announces the Formation of Kentucky-Based BioNeutral Services, Inc. and the Appointment of Frank Battafarano as Chairman and CEO of BioNeutral Services, Inc. 3AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results 2AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results 3AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results 4AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results 5AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results 6
... Sterile Bad-Parker blades offer the ... stainless steel technology, plus the exclusive ... and strength. Brad-Parker brand producer offer ... handles and disposable scalpels. Every blade ...
BD Beaver implant blade, 5.1 mm, angled 45, bevel up. matte finish. Designed for widening the incision for lens implantation. Beaver implant blades put precision and control in your hands, sterile....
BD Beaver Meniscus blade, 7 mm flat (4/bx, 1 bx/ca), specially designed maximum leverage and visibility, cutting edge: 7 mm, sterile....
... fit standard trial frames. They are made of optical ... display box. There are two sets available providing a ... that is that a patient can wear the prism ... allow the patient to adapt to the use of ...
Medicine Products: